Consensus report on ACE inhibitor renography for detecting renovascular hypertension

Journal of Nuclear Medicine

Volumn 37, Issue 11, 1996, Pages 1876-1882

  Taylor, Andrew ^a   Nally, Joseph ^b   Aurell, Mattias ^b   Blaufox, Donald ^b   Dondi, Maurizio ^b   Dubovsky, Eva ^b   Fine, Eugene ^b   Fommei, Enza ^b   Geyskes, Gijsbert ^b   Granerus, Goran ^b   Kahn, Daniel ^b   Morton, Kathryn ^b   Oei, Hong Yoe ^b   Russell, Charles ^b   Sfakianakis, George ^b   Fletcher, James ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

ACE inhibitor; renography; renovascular hypertension

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FUROSEMIDE; IODOHIPPURATE SODIUM I 123; IODOHIPPURATE SODIUM I 131; MERTIATIDE TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CLINICAL PROTOCOL; DOSE RESPONSE; DRUG CHOICE; HUMAN; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ARTERY STENOSIS; KIDNEY CLEARANCE; KIDNEY SCINTISCANNING; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENOGRAPHY; RENOVASCULAR HYPERTENSION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; HYPERTENSION, RENOVASCULAR; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; RADIOISOTOPE RENOGRAPHY; TECHNETIUM TC 99M MERTIATIDE; TECHNETIUM TC 99M PENTETATE;

EID: 10344260673     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Fletcher JW, Woolf SH Royal HD. Consensus development for producing diagnostic procedure guidlines: SPECT brain perfusion imaging with exametazime. J Nucl Med 1994;35:2003-2010.
2. Hillman BJ. Imaging advances in the diagnosis of renovascular hypertension. Am J Roentgenol 1989;153:5-14.
3. Fommei E, Ghione S, Hilson AJW, et al. Captopril radionuclide test in renovascular hypertension: a European multicenter study. Eur J Nucl Med 1993;20:625-644.
4. Sfakianakis GN, Bourgoignie JJ, Georgiou M, et al. Diagnosis of renovascular hypertension with ACE inhibition scintigraphy. Radiology Clin North Am 1993;31:831-848.
5. Holley KE, Hunt JC, Brown AL Jr, et al Renal artery stenosis: a clinical-pathologic study in normotensive and hypertensive patients. Am J Med 1964;37:14-22.
6. Prigent A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nucl Med 1993;20:625-644.
7. Oei HY. Dynamic and static renal imaging. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment, vol. 1, Churchill Livingstone, London. England: 1994;213-227.
8. Bubeck B, Brandau W, Weber E, et al. Pharmacokinetics of technetium-99m MAG3 in humans. J Nucl Med 1990;31:1285-1293.
9. Wilcox CS. Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension. Kidney International 1993;44:1379-1390.
10. Miyamori I, Yashuhara S, Takeda Y, et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension 1986;8:415-421.
11. Nally JV, Clarke HS, Windham JP, et al. Technetium-99m-DTPA renal flow studies in Goldblatt hypertension. J Nucl Med 1985;26:917-924.
12. Fine EJ, Blaufox MD The Einstein/Cornell collaborative protocol to assess efficacy and methodology in captopril scintingraphy. Early results in patients with essential hypertension. AJH 1991;4:716S-720S.
13. Nally JV, Clarke HS, Gupta BK, et al. Captopril renography in two kidney and one kidney Goldblatt hypertension in dogs. J Nucl Med 1987;28:1171-1179.
14. Wenting GJ, Derkx FHM, Lies HT, et al. Risk of angiotensin converting enzyme inhibition in renal artery stenosis. Kidney Int 1987;31:180-183.
15. Taylor A, Eshima D. Renal artery stenosis and ischemia: effect on renal blood flow and extraction fraction. Hypertension 1994;23:96-103.
16. Jonker GJ, Visscher CA, de Zeeuw D, et al. Changes in renal function induced by ACE-inhibition in the conscious two-kidney, one-clip Goldblatt hypertensive dog. Nephron 1992;60:226-231.
17. Dubovsky EV, Russell CD. Diagnosis of renovascular hypertension after renal transplantation. Am J Hypertens 1991;4:724S-730S.
18. Erley CM, Duda SH, Wakat J-P, et al. Noninvasive procedures for diagnosis of renovascular hypertension in renal transplant recipients: a prospective analysis. Transplantation 1992;54:863-867.
19. Fanti S, Dondi M, Corbelli C, et al. Evaluation of hypertensive patients with a solitary kidney using captopril renal scintigraphy with Tc-99m-MAG3. Nucl Med Commun 1993;1:969-975.
20. Shamlou KK, Drane WE, Hawkins IF, Fennell RS. Captopril renography and the hypertensive renal transplantation patient: a predictive test of therapeutic outcome. Radiology 1994;190:153-159.
21. Majd M, Potter BM, Guzzetta PC, et al. Effect of captopril on efficacy of renal scintigraphy in detection of renal artery stenosis [Abstract]. J Nucl Med 1983;24:P23.
22. Sfakianakis GN, Chandar J, Georgiou MF, et al. Diagnosis of renovascular hypertension from renal ischemia in children with the use of converting enzyme inhibition scintigraphy. In: Taylor A, Nally J, Thomsen H, eds. Radionuclides in nephrourology. Reston, VA: Society of Nuclear Medicine; in press.
23. Blaufox MD, Middleton ML, Bongiovanni J, Davis BR. A cost analysis of the detection of renovascular hypertension. J Nucl Med 1996;37:171-177.
24. Visscher CA, de Zeeuw D, Huisman RM. Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: a preliminary report. Nephrol Dial Transplant 1995;10:263-265.
25. Setaro JF, Chen CC, Hoffer PB, Black HR. Captopril renography in the diagnosis of renal artery stenosis and prediction of improvement with revascularization. Am J Hypertens 1991;4:S698-S705.
26. Kopecky RT, Deaver TF, McAfee JG. Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis. Hypertension 1987;10:181-188.
27. Elliot WJ, Martin WB, Murphy MB. Comparison of two noninvasive screening tests for renovascular hypertension. Arch Intern Med 1993;153:755-764.
28. Oei HY, Geyskes GG, Dorhout Mees EJ, Puylaert CBAJ. The significance of caaptopril renography in renovascular hypertension. Contr Nephrol 1987;56:95-103.
29. Blaufox MD, Dubovsky EV, Hilson AJW, et al. Report of the working party group on determining the radionuclide of choice. Am J Hypertens 1991;4:747S-748S.
30. Sfakianakis GN, Bourgoignie JJ, Jaffe D, et al. Single-dose captopril scintigraphy in the diagnosis of renovascular hypertension. J Nucl Med 1987;28:1383-1392.
31. Dondi M, Fanti S, De Fabritiis A, et al. Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med 1992;33:2040-2044.
32. 3 for renal scintigraphy after angiotensin-converting enzyme inhibition J Nucl Med 1991;32:424-428.
33. Roccatello D, Picciotto G, Rabbia C, et al. Prospective study on captopril renography in hypertensive patients. Am J Nephrol 1992;12:406-411.
34. Fommei E, Ghione S, Hilson AJW, et al. Captopril radionuclide test in renovascular hypertension: European multicenter study. In: O'Reilly PH, Taylor A, Nally JV, eds. Radionuclides in nephrourology, vol. I. Blue Bell. PA: Field and Wood Medical Periodicals, Inc.; 1994:33-37.
35. 3 renal scintigraphy in subjects with suspected renovascular hypertension. Nucl Med Commun 1994;15: 515-528.
36. Physicians' desk reference, 49th ed. Montvale, NJ: Medical Economics Data Production Co.; 1995:711.
37. Black HR, Bourgoignie JJ, Pickering T, et al. Report of the working party group for patient selection and preparation. Am J Hypertens 1991;4:745S-456S.
38. Erbsloh-Möller B, Dumas A, Roth D, et al. Furosemide I-131 hipppuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension. Am J Med 1991;90:23-29.
39. Physicians' desk reference, 49th ed. Montvale, NJ: Medical Economics Data Production Co.; 1995:1648.
40. Evans RR, Henzler MA, Weber EM, DiPette DJ. The effect of intravenous enalaprilat (MK-422) administration in patients with mild to moderate essential hypertension. J Clin Pharmacol 1987;27:415-418.
41. Kopecky RT, Thomas FD, McAfee JG. Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis. Hypertension 1987;10:181-188.
42. Cohen ML, Kurz KD, Schenck KW. Tissue angiotensin converting enzyme inhibition as an idex of the diposition of enalapril (MK-421 and metabolite MK-4221. J Pharmacol Exp Ther 1983;226:192-196.
43. Kopecky RT, McAfee JG, Thomas FD, et al. Enalaprilat-enhanced renography in a rat model of renovascular hypertension. J Nucl Med 1990;31:501-507.
44. Taylor A, Nally JV. Clinical applications of renal scintigraphy. Am J Roentgenol 1995;164:31-41.
45. Klingensmith WC III, Briggs DE, Smith WI. Technetium-99m-MAG3 renal studies: normal range and reproducibility of physiologic parameters as a function of age and sex. J Nucl Med 1994;35:1612-1617.
46. Geyskes GG, deBruyn AJG. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens 1991;4:685S-689S.
47. Setaro JF, Saddler MC, Chen CC, et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991;18:289-298.
48. Mann SJ, Pickering TG, Sos TA, et al. Captopril renography in the diagnosis of renal artery stenosis: Accuracy and limitations. Am J Med 1991;90:30-40.
49. 99mTc-DTPA gamma camera renography in the detection of renovascular hypertension. Nucl Med Commun 1993;14:169-175.
50. Meier GH, Sumpio B, Setaro JF. Captopril renal scintigraphy: a new standard for predicting outcome after renal revascularization. J Vasc Surg 1993;17:280-287.
51. Nally JW Jr, Chen C, Fine E, et al. Diagnostic criteria of renovascular hypertension with captopril renography. Am J Hypertens 1991;4:749S-752S.
52. Blaufox MD Should the role of captopril renography extend to the evaluation of chronic renal disease? [Editorial] J Nucl Med 1994;35:254-256.
53. Patrols F, Hignette C, Froissart M, Prigent A. Interpretation de la scintigraphie rénale avec prise de captopril: à propos d'un faux positif bilatéral. Médecine Nucléaire 1995;13:309-313.
54. Dubovsky EV, Russell CD, Japanwalla M, Mangipudy M. Bilateral response to captopril is nonspecific [Abstract]. Eur J Nucl Med 1991;18:575.
55. 99mTc-MAG3. Radionuclides in nephrourology. Blue Bell, PA: Field and Wood Medical Periodicals, Inc.; 1994:43-50.
56. 99mTc-DTPA and captopril. Radiology 1990;176:365-370.
57. 99mTc-DTPA captopril renogram: contribution of washout parameters to the diagnosis of renal artery stenosis. J Nucl Med 1993;34:1416-1419.
58. 131I Hippuran in renovascular hypertension (RVH) [Abstract]. J Nucl Med 1987;28(suppl):735.
59. Chandler ST, Gibson CJ, Elliott L. Models of renal blood flow and their use in the detection of renal artery stenosis. Nucl Med Comm 1990;11:427-436.
60. 99mTc-DTPA in the evaluation of patients with suspected renovascular hypertension. J Nucl Med 1990;31:1980-1985.
61. Gorten RJ. The actual clinical value of captopril renal function imaging. Eur J Nucl Med 1994;21:S39